Reteplase vs alteplase for ischemic stroke
RAISE trial tests the compound against tPA in China
Alteplase (recombinant tissue plasminogen activator or r-tPA) has been widely used for many years as a reperfusion therapy for ischemic stroke. Tenecteplase (TNK–tissue‐type plasminogen activator) has recently displaced alteplase at many stroke centers thanks to its single-bolus dosing, longer half-life, greater specificity for fibrin, and possible lowe…
Keep reading with a 7-day free trial
Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.